0
Neos Therapeutics, Inc. Banner Image

Neos Therapeutics, Inc. has reached its limit for free report views

Work for Neos Therapeutics, Inc.? Upgrade Your Profile and unlock all your annual reports.

Neos Therapeutics, Inc.

  • Ticker NEOS
    Exchange NASDAQ More
  • Industry Drug Manufacturers - Other More
  • Sector Healthcare More
Neos Therapeutics, Inc. Logo Image
  • 201-500 Employees
  • Based in Grand Prairie, Texas
Neos Therapeutics, Inc. (NASDAQ: NEOS) is a commercial-stage pharmaceutical company developing and manufacturing central nervous system (CNS)-focused products. The Company markets Adzenys XR-ODT® (amphetamine) extended-release orally disintegrating tablets (see Full Prescribing Information, including Boxed WARNING), Cotempla XR-ODT® (methylphenidate) extended-release orally disintegratingMore tablets (see Full Prescribing Information, including Boxed WARNING), and Adzenys-ER® (amphetamine) extended-release oral suspension (see Full Prescribing Information, including Boxed WARNING), all for the treatment of ADHD. The Company also has a development candidate, NT0502, for the treatment of sialorrhea in patients with neurological conditions.
Neos Therapeutics, Inc.

Most Recent Annual Report

Neos Therapeutics, Inc. MOST RECENT 2019 Annual Report and Form 10K

Report Locked. Neos Therapeutics, Inc. has reached its limit for free report views.

Older/Archived Annual Reports